160 related articles for article (PubMed ID: 11555629)
41. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
42. In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice.
Lesbordes JC; Bordet T; Haase G; Castelnau-Ptakhine L; Rouhani S; Gilgenkrantz H; Kahn A
Hum Mol Genet; 2002 Jul; 11(14):1615-25. PubMed ID: 12075006
[TBL] [Abstract][Full Text] [Related]
43. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
44. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
Storkebaum E; Lambrechts D; Dewerchin M; Moreno-Murciano MP; Appelmans S; Oh H; Van Damme P; Rutten B; Man WY; De Mol M; Wyns S; Manka D; Vermeulen K; Van Den Bosch L; Mertens N; Schmitz C; Robberecht W; Conway EM; Collen D; Moons L; Carmeliet P
Nat Neurosci; 2005 Jan; 8(1):85-92. PubMed ID: 15568021
[TBL] [Abstract][Full Text] [Related]
45. A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course.
Georgoulopoulou E; Gellera C; Bragato C; Sola P; Chiari A; Bernabei C; Mandrioli J
Muscle Nerve; 2010 Oct; 42(4):596-7. PubMed ID: 20740631
[TBL] [Abstract][Full Text] [Related]
46. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
Wang L; Gutmann DH; Roos RP
Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
[TBL] [Abstract][Full Text] [Related]
47. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
Kaspar BK; Lladó J; Sherkat N; Rothstein JD; Gage FH
Science; 2003 Aug; 301(5634):839-42. PubMed ID: 12907804
[TBL] [Abstract][Full Text] [Related]
48. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse.
Fischer LR; Culver DG; Davis AA; Tennant P; Wang M; Coleman M; Asress S; Adalbert R; Alexander GM; Glass JD
Neurobiol Dis; 2005; 19(1-2):293-300. PubMed ID: 15837585
[TBL] [Abstract][Full Text] [Related]
49. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
Yamanaka K; Miller TM; McAlonis-Downes M; Chun SJ; Cleveland DW
Ann Neurol; 2006 Jul; 60(1):95-104. PubMed ID: 16802286
[TBL] [Abstract][Full Text] [Related]
50. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Setoguchi Y; Abe K
Apoptosis; 2002 Aug; 7(4):329-34. PubMed ID: 12101392
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
52. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
[TBL] [Abstract][Full Text] [Related]
53. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.
Mourelatos Z; Gonatas NK; Stieber A; Gurney ME; Dal Canto MC
Proc Natl Acad Sci U S A; 1996 May; 93(11):5472-7. PubMed ID: 8643599
[TBL] [Abstract][Full Text] [Related]
54. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.
Martinez JA; Francis GJ; Liu WQ; Pradzinsky N; Fine J; Wilson M; Hanson LR; Frey WH; Zochodne D; Gordon T; Toth C
Neuroscience; 2008 Dec; 157(4):908-25. PubMed ID: 18951954
[TBL] [Abstract][Full Text] [Related]
55. Pleiotropic activity of systemically delivered angiogenin in the SOD1
Crivello M; O'Riordan SL; Woods I; Cannon S; Halang L; Coughlan KS; Hogg MC; Lewandowski SA; Prehn JHM
Neuropharmacology; 2018 May; 133():503-511. PubMed ID: 29486168
[TBL] [Abstract][Full Text] [Related]
56. Intramuscular delivery of HGF-expressing recombinant AAV improves muscle integrity and alleviates neurological symptoms in the nerve crush and SOD1-G93A transgenic mouse models.
Lee SH; Lee N; Kim S; Lee J; Choi W; Yu SS; Kim JH; Kim S
Biochem Biophys Res Commun; 2019 Sep; 517(3):452-457. PubMed ID: 31376938
[TBL] [Abstract][Full Text] [Related]
57. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
Alisky JM; Davidson BL
Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
[TBL] [Abstract][Full Text] [Related]
58. Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice.
Millecamps S; Nicolle D; Ceballos-Picot I; Mallet J; Barkats M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7582-7. PubMed ID: 11404466
[TBL] [Abstract][Full Text] [Related]
59. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
60. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS.
Ince PG; Tomkins J; Slade JY; Thatcher NM; Shaw PJ
J Neuropathol Exp Neurol; 1998 Oct; 57(10):895-904. PubMed ID: 9786240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
